Ontology highlight
ABSTRACT: Cardiovascular-kidney-metabolic (CKM) syndrome is a complex systemic disorder. In this study, we developed a urea-activated nanoparticle (T-PAAD NP) for targeted delivery of Empagliflozin to the renal S1 segment. Untargeted GC-MS-based metabolomics was performed to characterize metabolic reprogramming in kidney tissues of a CKM mouse model.
INSTRUMENT(S): Gas Chromatography MS - positive
PROVIDER: MTBLS13988 | MetaboLights | 2026-03-21
REPOSITORIES: MetaboLights
| Action | DRS | |||
|---|---|---|---|---|
| Kidney_1.CDF | Other | |||
| Kidney_10.CDF | Other | |||
| Kidney_11.CDF | Other | |||
| Kidney_12.CDF | Other | |||
| Kidney_13.CDF | Other |
Items per page: 1 - 5 of 64 |